BUND FINANCE

BUND FINANCE › Stocks › HLN

Haleon plc (HLN)

NYSE · Stock price, chart and technical analysis

US$9.08+0.0250 (+0.28%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$9.06
OpenUS$9.07
Day rangeUS$9.04 – US$9.13
52-week rangeUS$8.38 – US$11.28
Market capUS$39.85B
Volume19.46M
50-day averageUS$9.33
200-day averageUS$9.69
Beta0.25
Last dividend per shareUS$0.1980

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueGBP 9.5BGBP 10.9BGBP 11.3BGBP 11.2BGBP 11.0B
Net incomeGBP 1.4BGBP 1.1BGBP 1.0BGBP 1.4BGBP 1.7B
EPS (diluted)0.300.240.240.320.37
Gross margin62.3%60.6%61.6%61.9%64.2%
Operating margin17.2%16.8%17.7%19.6%21.9%
Net margin14.6%9.8%9.3%12.8%15.1%
Free cash flowGBP 1.1BGBP 1.7BGBP 1.8BGBP 2.1BGBP 2.3B
Total debtGBP 991.0MGBP 10.4BGBP 9.5BGBP 10.1BGBP 8.6B
CashGBP 414.0MGBP 684.0MGBP 1.0BGBP 2.3BGBP 1.3B

Compound annual growth: revenue 3.7% · net income 4.7% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E—23.5x27.1x
EV / EBITDA—15.4x16.5x
Operating margin22.7%—3.6%
Net margin14.6%—-0.0%
Debt / equity0.99—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation. The company reports in another currency: amounts are shown in that currency.

About Haleon plc

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryGB
CEOBrian James McNamara
Employees24,535
IPO date2022-07-25

Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially …

www.haleon.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice